Colorectal
Featured Articles
(Reuters) Oct 23, 2018 - AstraZeneca is plowing deeper into cancer immunotherapy through a wide-ranging deal with Innate Pharma, which includes the British group buying a 9.8 percent stake in the French biotech company. Tuesday’s agreement is a coup for Innate - run by former AstraZeneca executive Mondher Mahjoubi - which gains...
Read Article
(Spectrum) Oct 23, 2018 - Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the U.S. Food and Drug Administration (FDA) has approved KHAPZORY (levoleucovorin) for injection, a folate analog for...
Read Article
Latest Articles
December 12, 2018
December 12, 2018
December 11, 2018
December 10, 2018
November 30, 2018
November 28, 2018
November 21, 2018
November 20, 2018
View More
News Commentary
Editor Image
18 Oct, 2018 | by Tomasz M. Beer, MD
This is an exciting phase II result that suggests that carefully selected...
View Comment
Editor Image
20 Jul, 2018 | by H. Jack West, MD
Very unfortunate and very believable. Some proponents of complementary medicine...
View Comment
View More
OBR Green
There are no Colorectal OBR Green articles.
OBR Blog
There are no Colorectal blog entries.